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Abstract 
Adults with Sickle Cell Disease (SCD) are a significant population to study when 
considering self-medication behaviors, as they utilize multiple prescription drugs for 
management of symptoms related to their disease. Adults living with SCD will demonstrate 
adverse self-medication practices as recorded on the ActualMeds™ Medication Management 
System via use of Apple iPad® digital mobile device during a single interview, in order to 
identify the self-medication practices of adults with SCD. To demonstrate the ability of the 
ActualMeds™ program to conduct automated medication reconciliation on the Apple iPad®, it is 
necessary to tailor the program design for compatibility use with this device. ActualMeds™ is a 
team-based health care information technology program focused on providing web-based 
medication management and reconciliation (ActualMeds™, 2013). The ActualMeds™ program 
enables health care teams to conduct cost-effective medication reconciliation for high-risk 
patients, such as among adults living with SCD. The purpose of this study was to conduct 
usability testing by the student researcher with ActualMeds™ Medication Management System  
using the Apple iPad® digital mobile device, prior to conducting the investigation “Self-
Medication Practices of Adults with SCD” at the University of Connecticut Health Center. The 
technology was originally developed and validated in an NIH sponsored randomized, controlled 
trial in the School of Nursing at the University of Connecticut, where the intervention 
demonstrated it could improve patient outcomes and lower health care costs	  (Neafsey et al., 
2010). Results from usability testing were used 1) to systematically modify and tailor the 
ActualMeds™ program design compatibility for use via Apple iPad® and 2) to create the 
touchscreen computer tablet release version of the ActualMeds™ program for a large-scale use 
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in clinical care (on the Apple iPad® and other tablet devices). The usability-testing processes 
used in this feasibility study ensured an interface design adapted to the student researcher needs 
and preferences to allow her to effectively use the ActualMeds™ technology in a clinical setting 
among adults with SCD. This is the first report of a feasibility study of ActualMeds™ 
Medication Management System usability, targeting high-risk patients, on an Apple iPad® 
digital mobile device. 
 
Keywords: usability testing, healthcare informatics, sickle cell disease, self-medication practices 
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Statement of Research Problem 
Sickle cell disease (SCD) represents a group of serious inherited blood disorders 
associated with acute and chronic morbidity, recurrent unpredictable and unrelenting episodes of 
pain, increased risk of infection, stroke, organ damage and other debilitating complications 
(Ballas, 2010; 1995; Jacob, 2001; NIH, 2002; Platt, et al., 1994). As a result, adults with SCD are 
prescribed different medications to treat complications of SCD and other comorbidities (Odesina 
et al., 2010). In addition to the side effects (drowsiness) of the pain medications, such as opioids 
that they take for pain relief, it has been documented that many adults with SCD have cognitive 
deficiencies from ischemia to the brain (Vinchisky et al., 2010). It is unclear how these factors 
affect their understanding of treatment plan, follow up instructions and medication adherence. 
Furthermore, these are potential contributing factors to adverse self-medication practices. 
Because individuals with SCD are now outgrowing the specialty care of pediatricians, they often 
find themselves left to manage multiple medications and self-care interventions. Without 
understanding the self-medication practices of adults with SCD, we are not able to identify and 
begin to adequately meet their needs.  
 Neafsey et al. (2010) has demonstrated the potential for adverse self-medication 
practices in adults with hypertension, a chronic condition such as SCD, that lends itself to 
polypharmacy. The ActualMeds™ program enables health care teams to conduct cost-effective 
medication reconciliation for high-risk patients, such as among adults living with SCD. The 
usability of ActualMeds™ program via Apple iPad® must first be verified in a training 
environment, 1) to guide the design of system information architecture, 2) to test the software 
interface, and 3) to gather feedback information prior to conducting the feasibility study, “Self-
Medication Practices of Adults with SCD,” at the University of Connecticut Health Center. 
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Review of Literature  
Prevalence of Sickle Cell Disease 
Sickle cell disease (SCD) is an inherited autosomal recessive genetic disorder. SCD 
occurs most commonly, but is not limited to, families with a known ethnic heritage from India 
and Saudi Arabia, Africa, South and Central America, the Caribbean, and the Mediterranean 
region. 
In the United States, SCD affects an estimated 70,000–100,000 people, primarily in the 
African American population; SCD occurs in about 1 out of every 500 African American births. 
SCD also affects Hispanic Americans, occurring in more than 1 out of every 36,000 Hispanic 
American births (NIH 2013). Life expectancy for persons with SCD has recently increased from 
age fourteen in 1973 to the mid to late forties in 2004, transforming SCD into a long-term 
chronic illness. This chronic disorder may result in a lifetime of pain experiences and frequent 
hospitalizations (Jenerette, C.M., & Lauderdale, G., 2008). Because adults with SCD are living 
longer today, and are outgrowing the care of pediatricians and left to manage on their own, there 
is a need to identify self-medication practices in order to meet the needs of this vulnerable 
population. 
Hospital Readmissions 
According to the U.S. Agency for Healthcare Research and Quality, SCD was named the 
condition with the highest readmission rates in the year 2010, in a national study of healthcare 
cost and utilization. The study found 31.9% of patients with SCD were readmitted and this 
exceeded all other conditions, including heart failure, hepatitis, HIV, chronic renal failure, and 
others. This percentage may be better understood as over one in every four patients with SCD 
were readmitted. Costs for hospital stays due to complications of SCD were estimated at $488 
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million in 2004 (AHRQ, 2010). It is the intention of the research staff to survey self-medication 
practices in order to reduce adverse medication behaviors; Changes to medication regiment of 
study participants by their providers, such as reducing adverse medication behaviors in 
individuals, has the potential to reduce the hospital readmission rate of the adults with SCD 
interviewed in this feasibility study. 
Reducing adverse medication behaviors and promoting self-care are primary concerns to 
the efforts of nursing. The Institute of Medicine has cited medication adherence as of critical 
importance (Institute of Medicine, 2010). It is through this study that the student researcher 
hopes to gain experience with use of ActualMeds™ Medication Management System in the 
population of adults living with SCD. Ultimately, the student researcher will strive to improve 
the quality of life in this population. Future studies will extend data collection of self-medication 
practices, in order to inform an educational intervention that is community-based and culturally 
appropriate. 
Issues of Self-Medication  
Adults with SCD are a significant population to study when considering self-medication 
behaviors, as they utilize multiple prescription drugs for management of symptoms related to 
their disease. Studies have shown that mixed pain (chronic and acute) and the use of opioids 
prescribed by healthcare providers have negative effects on the functional status of adults with 
SCD, specifically in the physical and social domains (Ballas, 1995; McClish, et al., 2005). 
Neurologically intact adults with SCD with apparently normal intelligence and language 
capacities have been reported to show neurocognitive deficiencies due to the negative effects of 
pain experience and use of opioids to manage pain. This negatively affects the ability to plan, 
take control of self-management activities, and participate in vocational and social functions for 
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adults with SCD (Vinchinsky, et al., 2010; Wills, et al., 2010). Adults with SCD often lack self-
efficacy, positive coping responses, self-care management skills, and the ability to adhere to 
treatment regimen, or skills required for independent and/or supportive living related to such 
neurocognitive deficiencies (Jenerette, & Brewer, 2010; Jenerette, & Valrie, 2010; Jenerette, & 
Murdaugh, 2008; Jenerette, & Lauderdale, 2008; Jenerette, & Phillips, 2006).  Because 
individuals with SCD are living longer and transition from pediatric to adult care, there is a need 
to identify self-medication practices in order to meet the needs of this vulnerable population.  
Research Questions  
1. What are the self-medication practices of prescription and commonly used over-the 
counter medications and alcohol among adults with SCD? 
2. What are the adverse self-medication behaviors of adults living with SCD?   
In order to address these questions, the following must first be considered: 
3. How is the usability of ActualMeds™ program faring via Apple iPad® use, with 
respect to perceived system usability, system usefulness, system-use satisfaction, and 
interface time? 
Theoretical Framework 
 Initially derived from social cognitive theory, Self-efficacy theory attempts to explain and 
predict behavior (Bandura, 1977). Behavior, cognitive factors, and environmental influences are 
hallmark concepts of Social Cognitive Theory.  These concepts form the basis of a model with 
the relationship of three-pronged reciprocal determinism. Not necessarily equally, the three 
concepts interact bidirectionally. At different times, different factors may be the force driving the 
behavior. 
 The end result of self-efficacy expectations and outcome expectations is indeed behavior 
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(Bandura, 1982). As the patient develops self-efficacy and expected outcomes are identified, 
she/he evaluates his or her own ability to successfully complete the task. Thus, in the patient’s 
evaluative process, there exists an element of pragmatism. Specifically, if patients believe in 
their ultimate success related to their therapeutic process, self-efficacy and outcome expectations 
are increased. In this study, self-efficacy theory provided the underlying framework to guide the 
examination of patient behavior. 
 Self-efficacy theory suggests that self-efficacy expectations change over time with 
experience, given the opportunity to develop skills. It is an adaptive process. If a behavior were 
mastered, a desired outcome would result, as proposed by outcome expectations. Propositions 
related to outcome expectations and self-efficacy expectations differ—a person may expect that a 
certain outcome will result from a certain behavior, but not have confidence in his or her own 
ability to complete the task. 
Conceptual Definitions of Terms 
 Sickle Cell Disease (SCD) is an inherited disease and presents clinically as serious disorder 
in which the body produces “sickle-shaped” -- also referred to as “crescent-shaped” -- red blood 
cells. Sickle cells contain an abnormal protein structure called hemoglobin S. Sickled cells tend 
to block blood flow in vessels, limbs, and organs, causing pain, contributing to organ damage, 
and increasing risk for infection (National Heart Lung and Blood Institute, 2002).  
 The ActualMeds™ Medication Management System is a health care information 
technology, web-based system that enables team-based medication management and 
reconciliation at the point of care. ActualMeds™ technology was originally developed and 
validated in an NIH sponsored randomized, controlled trial in the School of Nursing at the 
University of Connecticut, where the intervention demonstrated it could improve patient 
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outcomes and lower health care costs (Neafsey et al., 2010). In a structured interview, clinicians 
use this tool to capture prescription and over the counter medication information, and other 
important patient self-medication information, such as conditions and symptoms (ActualMeds™ 
2013). Prior to this study, medications for SCD were loaded into the ActualMeds™ Medication 
Management system. 
 Self-medication practices are self-reported, clinician-entered data on prescription and over-
the-counter (OTC) medications and alcohol use. In a behavioral feasibility study, descriptive 
statistics of self-medication practices will be calculated using SPSS. Frequency distributions will 
be conducted and analyzed. 
Methods 
Research Design and Setting 
 Institutional Review Board approval was sought and approval granted from the UCHC 
with reciprocal approval granted by UConn Storrs. An exploratory descriptive study design will 
be used in the study. The University of Connecticut Health Center (UCHC) provides medical 
management to over 400 patients with SCD. The study will take place at UCHC. Patients who 
consent to participate in the study will be shown into a private room. The researcher will utilize a 
clinican-entry version of ActualMeds™ software program and enter participant self-reported 
information into the ActualMeds™ program. Dependent variables that will be measured include 
self-medication practices and adverse medication behaviors. 
 A convenience sample of adults with SCD that are patients of the Sickle Cell clinic will 
be recruited. Homogeneity will be considered as a control strategy. This will entail one sample of 
adults living with SCD. A study limitation is that the patients may not be representative of the 
general population of adults with SCD. Participants will be encouraged to be honest in the data 
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they will report to the researcher. When the researcher introduces the project, she will tell the 
participants there are no wrong answers, but that information is needed on medications patients 
take in their homes. 
Background of Instruments 
The ActualMeds™ Medication Use instrument was initially developed for the population 
living with hypertension with established content and construct validity (Neafsey et al., 2001; 
Neafsey & Shellman, 2002); however, it has been modified for use with adults with SCD.  The 
ActualMeds™ Medication Management System is a simple, secure web-based tool to help health 
care providers manage complex medication regimens in older adults or other high-risk patients 
(ActualMeds™, 2013). It is designed for use on a tablet computer and captures patient self-
reported, clinician-entered frequency and longitudinal use data on medications, supplements, and 
alcohol. Adherence to medication is measured from patient responses to questions related to 
what, when, and how they take each agent. Results from the data have been repeatedly tested in 
the touchscreen computer tablet formant with older adults (Lin et al., 2009; Neafsey et al., 2008; 
2009; 2010). 
Sampling Plan 
The study flyers describing the study (see Appendix A), participant criteria, and contact 
information of the researcher will be placed in the UCHC Sickle Cell Clinic, infusion room, and 
AACU. Health care providers at the UCHC Sickle Cell Clinic, infusion room, and AACU will 
share flyers with their patients advertising the study after they are educated about the study via 
poster presentation by the researcher, see Appendix B; ActualMeds™ images are unavailable 
due to the sensitivity and nature of the Non-Disclosure Agreement (Appendix C). Staff at the 
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UCHC Sickle Cell Clinic will mail flyers to their patients with SCD advertising the study. 
Interested participants will contact the researcher. The researcher will be in a room on the days 
patients with SCD are seen to meet with prospective participants to answer any questions the 
interested patients may have and screen for eligibility. Prospective participants can also contact 
the researcher by phone regarding eligibility. 
The prospective participants will meet with or arrange a meeting time with the student 
researcher to answer any questions the participant may have and obtain informed consent. The 
researcher will call to remind participants of the study enrollment appointment time arranged to 
meet with the researcher 1) to answer questions, 2) obtain informed consent. The phone call to 
participants will remind them to please bring a bag of their medications for the potential research 
study interview. The researcher will meet with the prospective participants in a private room 
previous to a UCHC appointment, approximately one hour in advance to a scheduled UCHC 
appointment with his or her health care provider. The student researcher will explain the study 
and obtain informed consent, after answering any questions the participant may have. 
This feasibility study will include 10-20 participants. Inclusion criteria are: 1) adults 
18yrs and older, 2) adults with diagnosis of SCD, 3) English speaking, and 4) any ethnic 
background. Patients with SCD under 18 years of age and people with sickle cell trait will be 
excluded. 
Threats to Internal Validity 
Patients may have a different level of understanding of their illness, based on their level 
of education and SES. Patients will be recruited based upon their regularly scheduled clinic 
appointments, May through July 2013. This selection might affect internal validity. The patients 
who choose to participate may be more highly motivated. The researcher will strive to recruit an 
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ethnically, economically and educationally diverse population. All instruments used have been 
previously validated. 
Threats to External Validity 
Only adults with SCD who are current patients at the University of Connecticut Health 
Center will have the ability to participate in the study. These patients may not be representative 
of the general population of adults living with SCD. For the purpose of this feasibility study, one 
location was used; however, future studies will include other settings. Data collection will be 
conducted in a private room at the Sickle Cell Clinic by the researcher, to minimize distractions. 
Instruments 
The ActualMeds™ Medication Management System (formerly PEP-NG) will be used for 
the Medication Use survey. The instrument has been used in several studies (Neafsey, Strickler, 
Shellman, & Chartier, 2002; Neafsey et al., 2008, 2010;Neafsey, Lutkus, Newcomb, & 
Anderson, 2009; Neafsey et al., 2007) investigating the self-medication practices of patients with 
hypertension. The instrument was used to collect self-reported data on medications prescribed 
and adherence, use of supplements, and alcohol intake. Adherence to the prescribed medication 
regime was addressed through the completion of a series of prompted questions describing what, 
when, and how the patients took their medications. Also, a three-item paper and pencil survey 
(see Appendix D) will address the participant’s hydration status with targeted hydration 
questions, developed by the researcher. 
It has been shown to be effective in increasing knowledge and self-efficacy related to the 
patient’s medication regime and decrease adverse self-medication practices in older adults with 
hypertension, a chronic condition such as SCD that lends itself to polypharmacy (Lin, Neafsey, 
Running head: SELF-MEDICATION PRACTICES: DESIGN AND METHODOLOGY 13	  
& Strickler, 2009; Neafsey, Strickler, Shellman, & Chartier, 2002; Neafsey, Anderson, Peabody, 
Lin, Strickler, & Vaughn, 2008, Neafsey, M’lan, Ge, Walsh, & Lin, 2010). 
Data Collection Procedure  
This study will require one visit and a follow up contact by phone 2 weeks following 
initial visit. Only one visit is required to complete the survey for this feasibility study. The entire 
process during initial interview will require about 30-45 minutes. Patients who consent to 
participate in the study will be shown into a private room previous to a regularly scheduled 
UCHC appointment, approximately one hour in advance to a regularly scheduled UCHC 
appointment with his or her health care provider. Participants will provide their private 
information in an informed consent hard copy paper form only. All paper consent forms will be 
kept in a research notebook. The student researcher will assign each participant a four digit ID 
number. The ID number is randomized and stored in the ActualMeds™ user ID bank, which is a 
password-protected secure online server. The student researcher will code the assigned four digit 
ID number to each participant on the participant’s consent form. Only the student researcher and 
the PI will have access to the coded consent form. The ActualMeds™ online server will only 
have access to de-identified information stored by the participant’s assigned four digit ID 
number. The ActualMeds™ online server will not have access to the coded data nor the research 
notebook, and therefore, the information connected to four six digit ID number will be de-
identified. All consent forms and the research notebook will be placed in a locked filing cabinet 
in the PI’s office in the Dowling North Medical Building. The principal investigator and the 
undergraduate nursing research student will be the only individuals with access to the raw data. 
         All participants will be assigned by a random ID number on the software program prior to 
data entry. Data collected on the ActualMeds™ program, including demographic and medication 
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use will be later downloaded onto a flashdrive file retained by the student researcher and PI, and 
downloaded to the research database via a secure server.  Gender and age information (collected 
on the consent form) will be added to this file after download. The ActualMeds™ server will not 
have the gender and age information. The secure server is password protected. The flashdrive 
containing electronic file will be placed in a locked filing cabinet in the PI’s office in the 
Dowling North building. Participants will be contacted by telephone 2 weeks after initial 
interview to follow-up self-care management. Participant responses during a 10 minute phone 
call will be documented into a research notebook as coded data with a four digit ID number. The 
research notebook will be placed in a locked filing cabinet in the PI’s office in the Dowling 
North Medical Building.  
Participants will bring prescription medication and over-the-counter (OTC) medications 
from home to assist their self-report of behaviors regarding the use of these medications. Self-
medication practices will be documented by the student researcher with regard to prescription 
medications, over-the-counter (OTC) medications, and current alcohol intake. This interview 
will not address illicit drugs; participants will not be asked about illicit drug use in this study. 
Each participant will be provided with a printed summary of the interview. The health care 
provider of each participant at the UCHC will be provided a printed summary of the interview by 
the student researcher before the regularly scheduled appointment that day following the research 
interview. This will provide an opportunity for the health care provider to review the information 
and make a clinical decision necessitated by the information; for example, we expect three types 
of summary report results and actions for health care providers to take: 1) No risk – providers 
will review information and continue plan of care; 2) Moderate risk – providers will make 
changes to participant medication regimen if necessary; 3) High risk – providers will make 
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changes and/or refer participants to UCHC Infusion Room or Emergency Dept for urgent care if 
necessary. 
The researcher will contact participants 2 weeks after the initial interview visit by 
telephone call. The purpose of the call will be to ask follow-up questions regarding what actions 
were taken after obtaining the survey results (see Appendix E). The phone call will require about 
10 minutes. 
Data Analysis Plan 
Coded data will be entered into an SPSS data file. Descriptive analyses will be conducted 
on all variables organized by race and age. Frequency distributions of the Adverse Self-
Medication Behavior Score will be analyzed. Because this is a small feasibility study, no 
conclusions will be made based on race or age. 
Timeline 
 The project proposal was written in the fall of 2012. The version I proposal was 
submitted to the institutional review board (IRB) at the University of Connecticut Health Center 
in March 2013. The version II proposal, revised per IRB chair comments (see Appendix F), was 
submitted to the IRB in April 2013. A letter of support was sought from the director of UCHC 
Sickle Cell clinic (see Appendix G). Final approval by the IRB for this expedited project was 
granted on May 9, 2013 (See Appendix H) 
Application to Nursing 
SCD is responsible for over one million hospital admissions annually and is the most 
common cause for hospital admission in persons over 65 years of age. Ultimately, the researcher 
will strive to improve the quality of life in this population. Future studies will extend data 
collection and compare men and women’s self-medication practices. 
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Usability Testing 
The usability of ActualMeds™ Medication Management System via Apple iPad® was 
tested by the student research in three timed sessions, in a manner similar to previous usability 
testing by APRNS of the earlier software version, PEP-NG (Lin et al., 2010). The student 
researcher developed medication lists typical of adults with SCD, based upon clinical experience. 
The knowledge of medications that adults with SCD take was derived from personal experiences 
in the nursing care of adults with SCD in UCHC inpatient hematology-oncology. Using such 
prior knowledge, the researcher developed hypothetical medication lists distinct for each trial. 
The lists were created with a range of 14-17 medications total, as polypharmacy is very 
commonly seen in this patient population, refer to Appendix I for medication list details for all 
trials. Also, typical information was provided by the student researcher, based upon clinical 
experience, for data entry such as health status, daily living, and self-reported nonadherence 
behaviors. The student researcher entered such data and simulated medication reconciliation in 
three timed trials. In the first time trial, an Apple iPad® was used without accessories. In the 
second trial, an Apple iPad® was accompanied with a stylus. In the third trial, an Apple iPad® 
was used with stylus and portable keyboard accessories (Appendix J) 
 In a similar manner to Lin et al. (2010), the student researcher engaged in a “think-aloud 
procedure” while entering data into the ActualMeds™ Medication Management System. The 
interface action and think-aloud expressions were captured via digital video, as the student 
researcher verbalized her thoughts during system interface. Then, a PSSUQ survey was 
completed (see Appendix K for PSSUQ template). The digital video footage was reviewed and 
transcribed, recorded comments supplemented the PSSUQ survey, respectively. 
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 The student researcher has continued to provide her opinion on the design of 
ActualMeds™, with respect to information architecture, graphic design, color, font, screen size 
preference, interactivity functions for data entry and retrieval, and ergonomic features, including 
use of stylus touch-screen interface and wireless keyboard. 
Results 
At this time, patients have not yet enrolled in the study “Self-Medication Practices of 
Adults with SCD.” The results included here are detail the student researcher’s experience with 
the usability testing of the ActualMeds™ program, in preparation for  study interviews with  
participant. Usability testing is necessary to verify appropriate conduct in prospective study 
interviews with participants, such as with respect to time. The results of the usability testing will 
aid the research staff and further development of ActualMeds™ with the knowledge of effective 
and less effective techniques employed.  
Verification of Usability Testing 
The student researcher utilized an Apple iPad® to conduct three trials of usability testing. 
In the first trial, only an Apple iPad® was utilized with touchscreen features. In the second trial, 
the Apple iPad® use was accompanied by the use of a stylus. In the third trial, the Apple iPad 
was utilized with a stylus as well as a wireless keyboard accessory. The results for the modified 
15 PSSUQ items are reported as follows. With regard to the usability testing, conceptual 
dimensions were associated with the following: (1) system usefulness (a five-item scale); (2) 
system usability (a six-item scale); (3) system-use satisfaction (a four-item scale). 
System Usability 
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 As seen in Table 2, the third usability trial was found to have significantly improved 
results, suggesting that the student researcher did not find using an iPad alone with touchscreen 
features to be usable. Results show that the student researcher demonstrated an improved 
usability experience with the iPad accompanied by a stylus, and an increased usability perception 
reported by the third trial with a stylus and accompanying keyboard accessory. 
System Usefulness 
 The student researcher reported a high usefulness rating for both trials 2 and 3, indicating 
that both the use of Apple iPad® with stylus and/or the use of Apple iPad® and stylus with 
keyboard are equally useful (Table 2). 
System-Use Satisfaction 
 The student researcher reported highest satisfaction with the use of Apple iPad with 
stylus and keyboard accessories, as seen in Trial 3 (Table 2). Results indicate a significantly low 
satisfaction rating for Apple iPad alone, without accessories. 
Interface Time 
 There was a twelve minute reduction in interface time between the Trial 1 and Trial 2 
usability testing, a ten minute reduction in interface time between Trial 2 and Trial 3 usability 
testing, and a 22 minute reduction in interface time between the Trial 1 and Trial 3 usability 
testing. This shows that the interface entry time in Trial 3 with the stylus and wireless keyboard 
incorporated into use was 1.6 times faster than with the iPad alone. This is necessary knowledge 
for the research staff prior to conducting “Self-Medication Practices of Adults with SCD.” 
Limitations 
With the student researcher’s solo usability testing in mind as precedent, it is necessary to 
conduct a formal usability study of the ActualMeds™ Medication Management System via the 
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use of a touchscreen Apple iPad®. Usability testing with Apple iPad® with prospective 
clinician-entry users at the Neag Comprehensive Cancer Clinic, such as RNs and advanced 
practice RNs (APRNs) of the ActualMeds™ Medication Management System must be 
conducted, in order to use ActualMeds™ in practice to capture the self-medication behaviors of 
adults with SCD and other vulnerable patient populations for which medication adherence and 
reducing adverse self-medication behaviors are concerns.  
Conclusion 
The student researcher has verified the usability of ActualMeds™ program via Apple iPad® use, 
with respect to perceived system usability, system usefulness, system-use satisfaction, and 
interface time. In order to promote time efficacy for use with patients in face-to-face interviews, 
the student researcher has determined the Apple iPad should be used with both accompanying 
stylus and keypad for implementing the ActualMeds™ Medication Management System in the 
investigation of “Self-Medication Practices of Adults with Sickle Cell Disease.” With this 
knowledge, the student researcher will  1) identify the self-medication practices of prescription 
and commonly used over-the counter medications and alcohol among adults with SCD, and 2) 
identify the adverse self-medication behaviors of adults living with SCD in the SURF-funded 
study approved by the University of Connecticut Health Center Institutional Review Board. 
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APPENDIX A 
Poster to recruit adults with Sickle Cell Disease 
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APPENDIX C nondisclosure agreement
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APPENDIX D paper and pencil survey items targeted at hydration status 
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APPENDIX E 
Follow-up Phone Call Interview Questionnaire: 
1) After the ActualMeds™ interview, has your health care provider made changes to your 
medicines? 
2) What change suggestions were made to the way that you take your medicines in the last 
two weeks? 
3) In the last two weeks, have you personally made any changes to the way that you take 
medications, on your own accord? 
4) Do you have any thoughts or concerns at this time, related to the ActualMeds™ study, 
that you would like me to know? 
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APPENDIX F IRB Chair Comments 
The following are comments from the IRB chair regarding your new study.  
Please let me know if you have any questions when addressing the changes. 
 
1. Please clarify that the data collected with be coded with a subject 
(randomized) number and linked with a master list, the master list should 
be stored separate from the data.  Describe how the subject (randomized) 
number is created.  Also address who will provide (create) the code, which 
should be the PI and you, not the program.  Clarify that only de-
identified data is shared with the server/program.  
 
2. Clarify that the flyers will not be mailed to SCD patients and specify 
where they will be posted.   Describe the process for the physicians 
handing the recruitment information sheet to patients.    
 
3. Decide when you will be calling the patients back after their initial 
visit.  2 days, 2 weeks or 30 days?  Address the questions being asked to 
make them appropriate for the time span for the call back. 
 
4. Clarify that the report will be given to the patients' health care 
provider following the interview and whether the report will be put in the 
medical chart.  Provide a letter from the director of the SC, Dr. Biree 
Andemariam supporting your study.   
 
5. Phone script should "ask" all questions regarding eligibility as 
described in the HIPAA Waiver #1.  Are you meeting with the potential 
subject at the UCHC clinic prior to their scheduled clinic visit?  
How/where will you record the patients information (name and telephone 
number) if they are determined eligible for the meeting?  This information 
should only be collected once they are eligible and agreed to meet with 
you. 
 
6.   ICF waiver, Item #1, indicate that the waiver is only for initial 
phone screen.  Item #2, correct response to collect name and phone number 
only if the potential subject is eligible.  Third sentence, correct to say 
"consent will be obtained...".  Item #3, Please address the question being 
asked. 
 
 The Protocol (page 4, data collection procedures), IRB Application and 
Consent must be re-written to address all these issues.  The chair has 
provided some hand written comments, please provide a fax number and I 
will fax them to you.  
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APPENDIX G
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APPENDIX H 
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APPENDIX I 
 Table 1 Trial 1 Medication List 
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Table 2 Trial 2 Medication List 
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Table 3 Trial 3 Medication List 
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APPENDIX J  
Table 1 Recorded interface sessions, student researcher completed data entry 
Timed Sessions Trial 1 iPad 
with 
touchscreen use 
Trial 2 iPad 
with stylus 
Trial 3 iPad 






57 45 35 
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ble 2 The Post-Study System Usability Questionnaire (PSSUQ1) 
Responses reported by student researcher in usability testing 
Question Trial 1 iPad, 
touchscreen use 
Trial 2 iPad with 
stylus 
Trial 3 iPad with 
stylus and wireless  
keyboard accessory 
1. Overall, I am satisfied with how easy it is to use 
this system. 
3 2 1 
2. It was simple to use this system. 3 2 1 
3. I could effectively complete the tasks and scenarios 
using this system. 
3 3 1 
4. I was able to complete the tasks and scenarios 
quickly using this system. 
7 3 1 
5. I was able to efficiently complete the tasks and 
scenarios using this system. 
5 2 1 
6. I felt comfortable using this system. 5 2 1 
7. It was easy to learn to use this sytem. 4 1 1 
8. I believe I could become productive quickly using 
this system. 
6 2 1 
9. The system gave error messages that clearly told 
me how to fix problems. 
1 1 1 
10. Whenever I made a mistake using the system, I 
could recover easily and quickly. 
1 2 2 
11. The information (such as on-line help, on-screen 
messages and other documentation) provided with 
this system was clear. 
2 1 11 
12. It was easy to find the information I needed. 1 2 1 
13. The information I provided for the system was 
easy to understand. 
1 2 1 
14. The information was effective in helping me 
complete the tasks and scenarios. 
1 2 1 
15. The organization of information on the system 5 3 2 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Likert scale range 1-7 used, number 1 as “strongly agree” to number 7 as “strongly disagree”	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screens was clear. 
 
 
Table 3 Usability findings--Summary of major recommendations by student researcher for 
improving the use of ActualMeds™ program 
Problem Frequency n2 (all trials) Proposed solution 
Scrolling feature attempted for 
use, NCD code entry 
16 1) Bar scanning (to be 
released in 2013); 2) develop 
scrolling feature; 3) type exact 
entry to avoid scrolling 
Menu selection items are 
limited in patient self-reported 
conditions, symptoms. 
6 1) Allow free-text feature for 
items to be included; 2) 
develop more comprehensive 
list for menu items, such as 
itching 
“Homeless” is not an available 
menu item for patient self-
reported living situation 
2 1) include “homeless” as a 
menu choice item, as this is 
seen in this particular patient 
population; 2) allow for a free 




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 n = number of times event occurred during all trials (total) usability study. 
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Table 4 Major teaching points from formal usability study 
1. ActualMeds™ has optimal visual design and usability when iPad® is used in horizontal 
position 
2. Allow more free text features, such as patient self-reported select conditions and symptoms. 
For example, pruritis or itching was not available to select from the menu; pruritis is commonly 
experienced in adults with SCD as a side effect of opioid medications for pain. 
3. Expand “living situation” to include lower SES population, such as “homeless” added as a 
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APPENDIX K 
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